MedPath

Clinical Trial to assess efficacy of Parsana Acupressure Therapy plate in Type II Diabetes mellitus, Anxiety, Joint Pai

Phase 3
Completed
Conditions
Health Condition 1: F411- Generalized anxiety disorderHealth Condition 2: M255- Pain in jointHealth Condition 3: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/09/057271
Lead Sponsor
PARSANA Health Centre Pvt Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
47
Inclusion Criteria

Every Participants should fulfill the following eligibility criteria to

participate in the study:

1. Patients of either sex between the age 18 to 65 years.

2. Patients with Type II Diabetes mellitus, who are under Oral anti hyperglycemic drugs on a regular basis and whose random

blood glucose level is = 250mg/dl.

3. Type II Diabetic patients associated with Generalized Anxiety

Disorder and Joint Pain.

4. Patients who fulfill DSM IV and ICD-10 diagnostic criteria for

GAD will be included in the study.

5. Sustention of Chronic musculoskeletal pain due to

osteoarthritis, lower back pain, rheumatic arthritis, neck shoulder-arm syndrome, diabetic neuropathy for at least

minimum of 3 months or even more.

Exclusion Criteria

The following will be excluded from the study:

1. Uncontrolled Type II Diabetic mellitus though on Oral

anti-hyperglycemic drugs i.e., = 250mg/dl.

2. Patients with joint deformities.

3. Patients with co-morbid psychiatric disorders.

4. Patients with any other psychiatric diagnosis other than GAD.

5. Patients who are on regular treatment with psychotropic drugs at

least four weeks prior to the study.

6. Patients who are substance abuse like alcohol, drugs etc.,

7. Patients who are diagnosed with significant depression.

8. Patients with other complicated medical conditions as per the

investigator discretion are excluded from the study.

9. Pregnant or lactating females and women in childbearing age

refusing to use double barrier contraceptive methods.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath